New York State Common Retirement Fund Tricida, Inc. Transaction History

New York State Common Retirement Fund

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 30, 2023	SELL	$0.14 - $12.49 $5 - $487	-39 Reduced 0.17%	23,126 $4,000
Q3 2022 Nov 08, 2022	BUY	$8.51 - $13.6 $2,255 - $3,604	265 Added 1.16%	23,165 $243,000
Q2 2022 Aug 04, 2022	BUY	$7.31 - $11.85 $167,399 - $271,365	22,900 New	22,900 $222,000
Q3 2021 Nov 02, 2021	SELL	$3.56 - $4.64 $850 - $1,108	-239 Closed	0 $0
Q2 2021 Aug 02, 2021	SELL	$3.95 - $5.41 $70,385 - $96,400	-17,819 Reduced 98.68%	239 $1,000
Q4 2020 Feb 08, 2021	SELL	$4.37 - $9.46 $930,831 - $2.02 Million	-213,005 Reduced 92.18%	18,058 $127,000
Q2 2020 Aug 07, 2020	BUY	$21.21 - $31.55 $2.85 Million - $4.24 Million	134,422 Added 139.09%	231,063 $6.35 Million
Q1 2020 May 06, 2020	BUY	$18.43 - $38.04 $1.42 Million - $2.93 Million	76,983 Added 391.61%	96,641 $2.13 Million
Q4 2019 Feb 05, 2020	SELL	$29.6 - $43.71 $79,920 - $118,017	-2,700 Reduced 12.08%	19,658 $742,000
Q2 2019 Aug 09, 2019	BUY	$31.16 - $39.46 $283,556 - $359,086	9,100 Added 68.64%	22,358 $882,000
Q1 2019 May 08, 2019	BUY	$19.96 - $38.62 $85,828 - $166,066	4,300 Added 48.0%	13,258 $512,000
Q4 2018 Feb 08, 2019	BUY	$23.57 - $32.33 $211,140 - $289,612	8,958 New	8,958 $211,000

30K

124K

46.5K

Ticker TCDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,668,900
Market Cap $557K
Description
Tricida, Inc. operates as a pharmaceutical company. It focuses on the development and commercialization of veverimer (TRC101), a non-absorbed orally-administered polymer that has completed Phase III trial to treat metabolic acidosis in patients with chronic kidney disease by binding and removing acid from the gastrointestinal track. The company ...

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

Stay updated on New York State Common Retirement Fund with notifications on news.